Biopharma Daily Stock Updates - 02/02/21

$XBI $163.24 +2% 📈

PIPELINE:

$VYGR +6% $NBIX terminated collaboration

$SAVA +141% Positive interim data

$DRRX +18% FDA approval of Posimir

$VBIV -3% PDUFA date Nov 30, 2021

$TVTX +11% Travere Therapeutics Announces Achievement of Interim Proteinuria Endpoint in the Ongoing Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

$VRNA +1% Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD

FINANCIAL:

$KRYS +3% Offering priced at $65/share

$ARQT +1% Prices offering $35/share

$LQDA +5% Completed acquisition of RareGen

$OTLK +2% Closes offering